Dr. Eric J. Eross is the founder and director of the Scottsdale Headache Center at ANI. He also currently serves as an Associate Clinical Professor at Arizona College of Osteopathic Medicine, clinical editor for the medical journal Headache Currents and a clinical investigator at Arizona Neurological Institute Research.
Prior to his current positions, Dr. Eross served as an associate neurology consultant, headache medicine specialist and clinical instructor at the Mayo Clinic and Mayo Clinic College of Medicine.
Dr. Eross graduated from Allegheny College with a B.S. degree in neurobiology; a major he personally created and has been offered at Allegheny College ever since. He attended medical school at Ohio University and completed his neurology residency at the University of Texas. His expertise in headaches was obtained by completing a two-year headache medicine fellowship at the Mayo Clinic in both Rochester, Minnesota, and Scottsdale, Arizona.
Dr. Eross has presented over 300 formal lectures and his research has been presented throughout the world, including London, Berlin, Rome, and Kyoto. He has published over 50 original papers, abstracts and book chapters. In addition, he has served as an investigator in over 60 clinical headache-related trials. To date, he has had the pleasure of treating nearly 15,000 headache sufferers.
His areas of special interest include the use of Botox® for the prevention of migraine, the relationship between sinus disease and migraine, idiopathic intracranial hypertension (pseudotumor cerebri), headaches secondary to cerebrospinal fluid leaks, and indomethacin responsive headache syndromes (IRHS). Such interests led to his development of the novel product Gliacin™, which is the only known therapy (natural or pharmaceutical) shown to be an effective, safe, and reliable backup to indomethacin in those who experience debilitating IRHS.
Dr. Eross was the founder of Glia Sciences and serves as the company’s current president. Glia Sciences is the exclusive maker of Gliacin™, which is now sold in over 30 states and five different countries. Dr. Eross believes in a patient-centered approach that stresses patient empowerment through education, and diverse, cutting-edge therapies, as well as ongoing compassionate care.